Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long Duration Activity and Metabolic Control After Spinal Cord Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03139344
Recruitment Status : Completed
First Posted : May 3, 2017
Results First Posted : February 16, 2023
Last Update Posted : February 16, 2023
Sponsor:
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Richard K Shields, University of Iowa

Brief Summary:
Skeletal muscle is the largest endocrine organ in the body, playing an indispensable role in glucose homeostasis. Spinal cord injury (SCI) prevents skeletal muscle from carrying out this important function. Dysregulation of glucose metabolism precipitates high rates of metabolic syndrome, diabetes, and other secondary health conditions (SHCs) of SCI. These SHCs exert a negative influence on health-related quality of life (HRQOL). New discoveries support that a low level of activity throughout the day offers a more effective metabolic stimulus than brief, episodic exercise bouts. The proposed study will translate this emerging concept to the population of individuals with SCI by using low-force, long-duration electrical muscle stimulation to subsidize daily activity levels. Recently, we demonstrated that this type of stimulation up-regulates key genes that foster an oxidative, insulin-sensitive phenotype in paralyzed muscle. We will now test whether this type of activity can improve glucose homeostasis and metabolic function in patients with chronic paralysis. We hypothesize that improvements in metabolic function will be accompanied by a reduction in SHCs and a concomitant improvement in self-reported HRQOL. The long-term goal of this research is to develop a rehabilitation strategy to protect the musculoskeletal health, metabolic function, and health-related quality of life of people living with complete SCI.

Condition or disease Intervention/treatment Phase
Spinal Cord Injuries Other: Low-frequency Exercise Other: High-frequency Exercise Not Applicable

Detailed Description:

Skeletal muscle is a critical organ for regulating glucose and insulin in the body as a whole, and post-spinal cord injury (SCI) adaptations in muscle severely undermine this capacity. Contemporary SCI rehabilitation for people with complete SCI does not intervene to protect the function of paralyzed skeletal muscle as a key regulator of metabolic homeostasis. Through its deleterious effects on multiple systems, metabolic disease is one of the leading sources of morbidity, mortality, and health care cost for this population.

In the non-SCI population, pervasive, frequent, low-magnitude muscle contractions can increase energy expenditure by 50.3% above sitting levels. The loss of this component of muscle activity contributes to the energy imbalance and metabolic dysregulation observed in SCI. Subsidizing low-magnitude muscle contractions may offer an important metabolic stimulus for people with SCI. The significance of this study is that it builds on previous work demonstrating healthful transcriptional and translational gene adaptations in response to electrical stimulation training in SCI. These adaptations may initiate improvements in systemic biomarkers of metabolic health and improvements in secondary health conditions and health-related quality of life.

In our previous work, we demonstrated that regular electrical stimulation of paralyzed muscle up-regulates PGC-1α, a key transcriptional co-activator for skeletal muscle and metabolic adaptation. Our previous work also indicates that electrical stimulation alters the expression of genes controlling mitochondrial biogenesis. However, we understand very little about the optimal amount of electrically-evoked muscle activity to deliver in order to promote positive metabolic adaptations. Long duration, low force contractions are likely to be most advantageous for promoting metabolic stability in people with chronic SCI, who also have osteoporosis and are unable to receive high force muscle contractions induced by conventional rehabilitation protocols. This study will intervene with a protocol of low-force, long-duration muscle stimulation designed to instigate systemic metabolic adaptations. In the proposed study we hypothesize that gene-level adaptations will yield tissue-level improvements in glucose utilization that facilitate systemic improvements in clinical markers of metabolic control, culminating in fewer secondary health conditions and enhanced health-related quality of life.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 89 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Long Duration Activity and Metabolic Control After Spinal Cord Injury
Actual Study Start Date : August 1, 2015
Actual Primary Completion Date : April 1, 2022
Actual Study Completion Date : April 1, 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Acute gene regulation: low frequency
Adaptations in gene regulation in response to single-session low-frequency exercise.
Other: Low-frequency Exercise
The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.

Experimental: Acute gene regulation: high frequency
Adaptations in gene regulation in response to single-session high-frequency exercise.
Other: High-frequency Exercise
The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.

Experimental: Training study: low frequency
Adaptations in gene regulation, systemic metabolic markers, and patient-report metrics in response to training with low-frequency exercise.
Other: Low-frequency Exercise
The quadriceps/hamstrings will perform exercise via the application of low-frequency electrical stimulation.

Experimental: Training study: high frequency
Adaptations in gene regulation in response to training with high-frequency exercise.
Other: High-frequency Exercise
The quadriceps/hamstrings will perform exercise via the application of high-frequency electrical stimulation.

No Intervention: Comparator cohort
Participants will undergo selected outcome measures to provide comparison values for Experimental arms.



Primary Outcome Measures :
  1. Acute Gene Regulation: NR4A3 mRNA Expression Pre and Post-Stimulation [ Time Frame: 3 hours after a single session of electrical stimulation ]
    Acute post-stimulation effect upon skeletal muscle nuclear receptor subfamily 4 group A member 3 (NR4A3) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.

  2. Acute Gene Regulation: PGC1-alpha mRNA Expression Pre and Post-Stimulation [ Time Frame: 3 hours after a single session of electrical stimulation ]
    Acute post-stimulation effect upon skeletal muscle peroxisome proliferator-activated gamma coactivator (PGC1-alpha) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.

  3. Acute Gene Regulation: ABRA mRNA Expression Pre and Post-Stimulation [ Time Frame: 3 hours after a single session of electrical stimulation ]
    Acute post-stimulation effect upon skeletal muscle actin binding Rho activating protein (ABRA) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.

  4. Acute Gene Regulation: PDK4 mRNA Expression Pre and Post-Stimulation [ Time Frame: 3 hours after a single session of electrical stimulation ]
    Acute post-stimulation effect upon skeletal muscle pyruvate dehydrogenase kinase 4 (PDK4) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.

  5. Post-training Gene Regulation: MYH6 mRNA Expression Baseline and Post-Training [ Time Frame: 6 months ]
    Pre- and post-training skeletal muscle myosin heavy chain 6 (MYH6) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.

  6. Post-training Gene Regulation: MYL3 mRNA Expression Baseline and Post-Training [ Time Frame: 6 months ]
    Pre- and post-training skeletal muscle myosin light chain 3 (MYL3) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.

  7. Post-training Gene Regulation: MYH7 mRNA Expression Baseline and Post-Training [ Time Frame: 6 months ]
    Pre- and post-training skeletal muscle myosin heavy chain 7 (MYH7) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.

  8. Post-training Gene Regulation: ACTN3 mRNA Expression Baseline and Post-Training [ Time Frame: 6 months ]
    Pre- and post-training skeletal muscle actin 3 (ACTN3) expression, measured via muscle biopsy and exon array analysis. Probe summarization and probe set normalization were performed using robust multichip average, which included background correction, quantile normalization, log2 transformation and median polish probe set summarization. 0 represents no mRNA expression and higher values represent greater expression compared to all genes in the microarray.

  9. Post-training Metabolism: Fasting Insulin [ Time Frame: 6 months ]
    Pre- and post-training fasting insulin, measured via venipuncture and standard laboratory assays

  10. Post-training Metabolism: Fasting Glucose [ Time Frame: 6 months ]
    Pre- and post-training fasting glucose, measured via venipuncture and standard laboratory assays

  11. Post-training Metabolism: Fasting Glucose-insulin Ratio [ Time Frame: 6 months ]
    Pre- and post-training ratio of fasting glucose to fasting insulin, measured via venipuncture and standard laboratory assays

  12. Post-training Metabolism: Fasting Hemoglobin A1c (HBA1c) [ Time Frame: 6 months ]
    Pre- and post-training fasting Hemoglobin A1C (HbA1c), measured via venipuncture and standard laboratory assays

  13. Post-training Metabolism: C-reactive Protein (CRP) [ Time Frame: 6 months ]
    Pre- and post-training C-reactive protein (CRP), measured via venipuncture and standard laboratory assays

  14. Pre-training Subject-report Measures: PROMIS Physical Health [ Time Frame: Baseline ]

    Pre-training Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Health - Physical health T-score

    Theoretical minimum = 16.2, Theoretical maximum = 67.7, higher scores signify more of the construct being measured (eg. physical health). US population mean = 50, SD = 10.


  15. Pre-training Subject Report Measures: PROMIS Mental Health [ Time Frame: Baseline ]

    Pre-training Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Health - Mental health T-score

    Theoretical minimum = 21.2, Theoretical maximum = 67.6, higher scores signify more of the construct being measured (eg. mental health). US population mean = 50, SD = 10.


  16. Post-training Subject-report Measures: PROMIS Physical Health [ Time Frame: 6 months ]

    Pre- and post-training Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Health - Physical health T-score

    Theoretical minimum = 16.2, Theoretical maximum = 67.7, higher scores signify more of the construct being measured (eg. physical health). US population mean = 50, SD = 10.


  17. Post-training Subject-report Measures: PROMIS Mental Health [ Time Frame: 6 months ]

    Pre- and post-training Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Health - Mental health T-score

    Theoretical minimum = 21.2, Theoretical maximum = 67.6, higher scores signify more of the construct being measured (eg. mental health). US population mean = 50, SD = 10.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Motor complete SCI (AIS A-B)

Exclusion Criteria:

  • Pressure ulcers, chronic infection, lower extremity muscle contractures, deep vein thrombosis, bleeding disorder, recent limb fractures, pregnancy, metformin or other medications for diabetes

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03139344


Locations
Layout table for location information
United States, Iowa
University of Iowa
Iowa City, Iowa, United States, 52242
Sponsors and Collaborators
Richard K Shields
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
Layout table for investigator information
Principal Investigator: Richard K Shields, PhD, PT University of Iowa
  Study Documents (Full-Text)

Documents provided by Richard K Shields, University of Iowa:
Publications:

Layout table for additonal information
Responsible Party: Richard K Shields, Professor, University of Iowa
ClinicalTrials.gov Identifier: NCT03139344    
Other Study ID Numbers: 201503732
R01HD082109 ( U.S. NIH Grant/Contract )
First Posted: May 3, 2017    Key Record Dates
Results First Posted: February 16, 2023
Last Update Posted: February 16, 2023
Last Verified: January 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Richard K Shields, University of Iowa:
metabolism
exercise
glucose
secondary health conditions
quality of life
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Wounds and Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System